- 期刊
Regulation of Suppressors of Cytokine Signaling as a Therapeutic Approach in Autoimmune Diseases, with an Emphasis on Multiple Sclerosis
延伸閱讀
- Huang, P. C. (2018). Soluble Siglec-14 is generated by alternative splicing and suppresses myeloid inflammatory responses [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201803214
- 詹華蓁（2007）。Suppressor of Cytokine Signaling 1 (SOCS1) Gene in Patients with Rheumatoid Arthritis〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-3007200711091800
- 吳健嘉（2014）。Regulation of growth and suppressor of cytokine signaling gene in the androgen-dependent and androgen-independent prostate cancer cells〔碩士論文，國立中央大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0031-0412201511570936
- Duffy, S. S., Lees, J. G., & Taylor, G. M. (2014). The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Multiple Sclerosis International, (2014), 56-72. https://doi.org/10.1155/2014/285245
- Farrugia, M., & Baron, B. (2017). The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism. International Journal of Inflammation, 2017(), 176-187. https://doi.org/10.1155/2017/8391230